| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.3109/S10165-012-0639-4 |
| P698 | PubMed publication ID | 22552437 |
| P2093 | author name string | Wei Huang | |
| Liang Sun | |||
| Wen-Jia Peng | |||
| Ye-Huan Sun | |||
| Xiu-Jun Zhang | |||
| Guo-Peng Gao | |||
| Sai Hou | |||
| Han-Fei Wang | |||
| Xiao-Jiao Ge | |||
| P2860 | cites work | Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study | Q21195665 |
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis | Q24812184 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease | Q28212615 | ||
| Association between PADI4 and rheumatoid arthritis: a replication study | Q28275244 | ||
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci | Q28281906 | ||
| Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins | Q31460983 | ||
| Epidemiology and genetics of rheumatoid arthritis | Q34731244 | ||
| Genetic basis of rheumatoid arthritis. | Q36323135 | ||
| Association between PADI4 and rheumatoid arthritis: a meta-analysis | Q36383132 | ||
| PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients | Q37943506 | ||
| Rheumatoid arthritis. Pathophysiology and implications for therapy | Q38019708 | ||
| Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis | Q46453983 | ||
| Genetic and genomic studies of PADI4 in rheumatoid arthritis | Q57667794 | ||
| PADI4 polymorphism predisposes male smokers to rheumatoid arthritis | Q58234815 | ||
| P2507 | corrigendum / erratum | Erratum to: PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis | Q50026295 |
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 50-60 | |
| P577 | publication date | 2012-05-03 | |
| P1433 | published in | Modern Rheumatology | Q15752709 |
| P1476 | title | PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis | |
| P478 | volume | 23 |
| Q37351587 | A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22 |
| Q38609269 | Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis |
| Q34036484 | Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study |
| Q37716563 | Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis |
| Q38612492 | Meta-analysis of the association between PADI4 -92C/G polymorphism and rheumatoid arthritis in the Chinese population |
| Q35067455 | PADI2 is significantly associated with rheumatoid arthritis |
| Q47971862 | Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation |
| Q55402490 | Peptidylarginine deiminase 4 -104C/T polymorphism and risk of rheumatoid arthritis: A pooled analysis based on different populations. |
| Q86301346 | Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases |
| Q50181592 | The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review |
| Q50026295 | Erratum to: PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis | main subject | P921 |
Search more.